Maryland’s Leadership in Traumatic Brain Injury (TBI) Prevention,
Diagnosis and Treatment - with a Positive Impact for Wounded Warriors and Athletes
2:30 – 3:30 p.m. Treatment – What’s Working and What Is Under Development?
While current TBI treatment is supportive and not yet restorative, advances in the use and development of neuroprotectors, protein inhibitors, pharmacological and stem cell therapies are being made daily. Learn about the current state of TBI treatment and possibilities for the future.
Alan Faden, M.D., Professor in Trauma, University of Maryland School of Medicine
Richard Garr, CEO, NeuralStem
Joshua Chenowith, PhD., Investigator, Brain Development Division, Lieber Foundation
Bruce Jarrell, M.D., Dean, University System of Maryland
3:30 – 4:30 p.m. Diagnosis – The Latest in Brain Injury Assessment
Accurate and early diagnosis of the level of injury in TBI is key to effective treatment. Learn about the challenges with validating novel diagnostic devices for TBI, and the neuropsychological, imaging, biomarker measurement, and other TBI assessment technologies currently being used or in development.
Robert Stevens, M.D., Associate Professor, Division of Neurosciences Critical Care, Johns Hopkins University School of Medicine
Vassilis Koliatsos, M.D., Associate Professor, Division of Neuropathology , Johns Hopkins University Medical School
Rochelle Tractenberg, Ph.D., Assistant Professor, Department of Neurology, Georgetown University Medical School
David Beylin, Ph.D., CEO, Brain Biosciences
David Smith, Head of Therapeutic Cell Solutions, Lonza Walkersville Inc.